BCTX   $4.19  1.45% Market Closed After Close 4.1981 0.19%

BriaCell Therapeutics Corp.
Total Cash 862.09K
totalCashPerShare 0.047
EBITDA -33.25M
Total Debt 0.00
quickRatio 0.214
currentRatio 0.49
Total Revenue
debtToEquity
Revenue/Share
ROA -1.26113
ROE
grossProfits
freeCashflow -10.83M
operatingCashflow -24.13M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 11.73M
forwardPE -1.8076923
floatShares 15.09M
sharesOutstanding 36.18M
sharesShort 727.57K
sharesShortPriorMonth 1.65M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.13%
Short Ratio help_outline 0.14%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue -0.13
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -4.79M
trailingEps -0.28%
forwardEps -0.39%
enterpriseToEbitda -0.35
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.3 4Q 2024
institutionsCount 28
lastUpdated Nov. 7, 2024, 4:56 a.m.